国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
6期
61-63
,共3页
围麻醉期%参附注射液%急性失血性休克%预扩容治疗
圍痳醉期%參附註射液%急性失血性休剋%預擴容治療
위마취기%삼부주사액%급성실혈성휴극%예확용치료
Peri-operationai period%Shenfu injection%Hemorrhagic hypovolemic shock%Pre-expan-sion treatment
目的 观察围麻醉期参附注射液预扩容治疗在抢救急性失血性休克病人中的应用及效果评价,探讨参附注射液在预扩容治疗应用于急性失血性休克围术期治疗的可行性和临床意义.方法 选择急性失血性休克病人50例,随机分成观察组(Ⅰ组,n=25例)和对照组(Ⅱ组,n=25例).两组病人气管插管后行全身麻醉,Ⅰ组麻醉后即给予参附注射液100ml加入5%葡萄糖注射液500ml和预扩容治疗液(指胶体液中分子量羟乙基淀粉6%贺斯或万汶)静脉滴注;Ⅱ组给予5%葡萄糖氯化钠注射液500ml静脉滴注.其它输血、扩血管等抗休克治疗措施两组相同.监测注药后30、60、120min各时间段的血压、心率、心排血量(CO)及尿量的变化,记录两组的出血量和输液输血量.对比观察两组注药后的动脉血气变化.结果 ①Ⅰ组静注参附注射液和预扩容治疗液后30、60min,血压回升、心排血量(CO)回升、心率下降明显早于Ⅱ组(P<0.05);尿量在1 h和2 h时与Ⅱ组有极显著差异(P<0.05或P<0.01).②注药后90 min Ⅰ组血气分析各项指标明显升高,与Ⅱ组比较有显著性差异(P<0.0 5或P<0.01).结论 围麻醉期参附注射液在预扩容治疗急性失血性休克中,能迅速恢复血流动力学并稳定,改善微循环和组织代谢,在促进休克的复苏,提高围术期的安全性等方面有较好的疗效.
目的 觀察圍痳醉期參附註射液預擴容治療在搶救急性失血性休剋病人中的應用及效果評價,探討參附註射液在預擴容治療應用于急性失血性休剋圍術期治療的可行性和臨床意義.方法 選擇急性失血性休剋病人50例,隨機分成觀察組(Ⅰ組,n=25例)和對照組(Ⅱ組,n=25例).兩組病人氣管插管後行全身痳醉,Ⅰ組痳醉後即給予參附註射液100ml加入5%葡萄糖註射液500ml和預擴容治療液(指膠體液中分子量羥乙基澱粉6%賀斯或萬汶)靜脈滴註;Ⅱ組給予5%葡萄糖氯化鈉註射液500ml靜脈滴註.其它輸血、擴血管等抗休剋治療措施兩組相同.鑑測註藥後30、60、120min各時間段的血壓、心率、心排血量(CO)及尿量的變化,記錄兩組的齣血量和輸液輸血量.對比觀察兩組註藥後的動脈血氣變化.結果 ①Ⅰ組靜註參附註射液和預擴容治療液後30、60min,血壓迴升、心排血量(CO)迴升、心率下降明顯早于Ⅱ組(P<0.05);尿量在1 h和2 h時與Ⅱ組有極顯著差異(P<0.05或P<0.01).②註藥後90 min Ⅰ組血氣分析各項指標明顯升高,與Ⅱ組比較有顯著性差異(P<0.0 5或P<0.01).結論 圍痳醉期參附註射液在預擴容治療急性失血性休剋中,能迅速恢複血流動力學併穩定,改善微循環和組織代謝,在促進休剋的複囌,提高圍術期的安全性等方麵有較好的療效.
목적 관찰위마취기삼부주사액예확용치료재창구급성실혈성휴극병인중적응용급효과평개,탐토삼부주사액재예확용치료응용우급성실혈성휴극위술기치료적가행성화림상의의.방법 선택급성실혈성휴극병인50례,수궤분성관찰조(Ⅰ조,n=25례)화대조조(Ⅱ조,n=25례).량조병인기관삽관후행전신마취,Ⅰ조마취후즉급여삼부주사액100ml가입5%포도당주사액500ml화예확용치료액(지효체액중분자량간을기정분6%하사혹만문)정맥적주;Ⅱ조급여5%포도당록화납주사액500ml정맥적주.기타수혈、확혈관등항휴극치료조시량조상동.감측주약후30、60、120min각시간단적혈압、심솔、심배혈량(CO)급뇨량적변화,기록량조적출혈량화수액수혈량.대비관찰량조주약후적동맥혈기변화.결과 ①Ⅰ조정주삼부주사액화예확용치료액후30、60min,혈압회승、심배혈량(CO)회승、심솔하강명현조우Ⅱ조(P<0.05);뇨량재1 h화2 h시여Ⅱ조유겁현저차이(P<0.05혹P<0.01).②주약후90 min Ⅰ조혈기분석각항지표명현승고,여Ⅱ조비교유현저성차이(P<0.0 5혹P<0.01).결론 위마취기삼부주사액재예확용치료급성실혈성휴극중,능신속회복혈류동역학병은정,개선미순배화조직대사,재촉진휴극적복소,제고위술기적안전성등방면유교호적료효.
Objective To observe the Senate anesthesia injection in the pre-expansion treatment of acute hemorrhagic shock patients and evaluate the results, explore the Shenfu injection in the pre-expansion used in the treatment of acute hemorrhagic shock perioperative treatment of the feasibility of And clinical significance.Methods Acute hemorrhagic shock patients were randomly divided into 50 cases of the observation group (I group, n = 25) and the control group (cn group, n = 25). Two groups of patients with general anesthesia endotra-cheal intubation later. Group I after the Narcotic give Shenfu injection 100ml in 5% glucose injection 500ml intravenous fluid therapy and pre-expansion (colloidal refers to the liquid molecular.weight hydroxyethyl starch 6% HES or Timor million); II group 5% Glucose and sodium chloride injection 500ml intravenous drip. Other blood transfusion, such as vasodilative anti-shock treatment 2, the same group. Monitoring 30,60,120 min after the injection of all time blood pressure, heart rate, cardiac output (CO) and volume changes in Group ¢n of the record amount of bleeding and blood transfusion volume. Compare the two groups were observed after injection of changes in arterial blood gases. Results ① I results of the Group Participation intravenous injection and pre-expansion treatment of liquid after 30, 60 min, blood pressure picked up, cardiac output (CO rebound), heart rate decreased significantly with the early II group (P < 0.05); in the urine 1 h And 2 h with the group II a very significant difference (P<0.05 orP<0.01).② Injection after 90 min ⒌¢n group of blood gas analysis and indicators increased II group were significantly different (P < 0.05 orP < 0.01 ). Conclusion Conclusions of the Senate anesthesia injection in the pre-expansion in the treatment of acute hemorrhagic shock, and rapid restoration of hemodynamic stability, improve microcirculation and metabolism of the organization to promote the recovery of shock, Perioperative to increase security in areas such as better Effect.